Prognosis
Teva’s Adderall Shortage Seen Continuing Into March
- Agency says there’s a national shortage of the medication
- Teva is the largest manufacturer of the ADHD drug in the US
Ten milligram tablets of Adderall.
Photographer: JB Reed/Bloomberg
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd.’s shortage of Adderall is expected to last through March, longer than the two to three months the company said last week, according to US regulators.
The popular treatment for attention-deficit/hyperactivity disorder has been in short supply since at least August, leaving people racing to fill prescriptions and find pharmacies with the elusive medication in stock. Demand for the drug is at an all-time high, and Teva sells more Adderall in the US than any other drug company.